-
Views
-
Cite
Cite
Nathalie Vermeulen, Ingrid Arijs, Sofie Joossens, Severine Vermeire, Stefan Clerens, Karolien Van den Bergh, Georges Michiels, Lutgarde Arckens, Frans Schuit, Leentje Van Lommel, Paul Rutgeerts, Xavier Bossuyt, Anti–α-enolase Antibodies in Patients with Inflammatory Bowel Disease, Clinical Chemistry, Volume 54, Issue 3, 1 March 2008, Pages 534–541, https://doi.org/10.1373/clinchem.2007.098368
Close - Share Icon Share
Abstract
Background: Patients with inflammatory bowel disease (IBD) carry autoantibodies such as perinuclear antineutrophil cytoplasmic antibodies (pANCA). α-Enolase has been proposed as a target antigen in IBD. We evaluated the prevalence and diagnostic value of anti–α-enolase antibodies in IBD and related disorders.
Methods: We used a classic proteomic approach with extracts from granulocytes and pANCA-positive ulcerative colitis (UC) sera to confirm α-enolase as a target antigen. By means of Western blot analysis, we screened a cohort of 525 subjects for the presence of anti–α-enolase antibodies. We performed GeneArray experiments on RNA extracted from colonic mucosal biopsies from 35 IBD and 6 control patients.
Results: We detected anti–α-enolase antibodies 49.0% of patients with UC, 50.0% of patients with Crohn’s disease, 30.5% of patients with primary sclerosing cholangitis, 37.8% of patients with autoimmune hepatitis, 34.0% of patients with ANCA-positive vasculitis, 31.0% of non-IBD gastrointestinal controls, and 8.5% of healthy controls. Gene array experiments showed a significant upregulation of α-enolase mRNA in colonic mucosal biopsies from patients with IBD, but not from controls. There was no association between the presence of pANCA and anti–α-enolase antibodies. Preabsorption with α-enolase did not eliminate the pANCA pattern on indirect immunofluorescence.
Conclusions: Anti–α-enolase antibodies are present in a substantial proportion of patients with IBD, patients with various inflammatory/autoimmune disorders, and non-IBD gastrointestinal controls. Therefore, anti–α-enolase antibodies are of limited diagnostic value for the diagnosis of IBD.
